Nanoparticles target distinct dendritic cell populations according to their size.
The efficiency of a vaccine largely depends on the appropriate targeting of the innate immune system, mainly through prolonged delivery of antigens and immunomodulatory substances to professional antigen-presenting cells in the lymphoid environment. Particulate antigens, such as virus-like particles...
主要な著者: | Manolova, V, Flace, A, Bauer, M, Schwarz, K, Saudan, P, Bachmann, M |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2008
|
類似資料
-
Nanoparticles target distinct dendritic cell populations according to their size
著者:: Manolova, V, 等
出版事項: (2007) -
Cutting edge: limited specialization of dendritic cell subsets for MHC class II-associated presentation of viral particles.
著者:: Keller, SA, 等
出版事項: (2010) -
Adjusted particle size eliminates the need of linkage of antigen and adjuvants for appropriated T cell responses in virus-like particle-based vaccines.
著者:: Gomes, A, 等
出版事項: (2017) -
Cytokine production by peripheral blood cells following therapy with a combined vaccine of allergen and QbG10
著者:: Manolova, V, 等
出版事項: (2008) -
Innate signaling regulates cross-priming at the level of DC licensing and not antigen presentation.
著者:: Keller, SA, 等
出版事項: (2010)